These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
83 related items for PubMed ID: 8943671
1. Comparison of induction chemotherapy before radiotherapy with radiotherapy only in patients with locally advanced squamous cell carcinoma of the lung. The Swedish Lung Cancer Study Group. Brodin O, Nou E, Mercke C, Lindén CJ, Lundström R, Arwidi A, Brink J, Ringborg U. Eur J Cancer; 1996 Oct; 32A(11):1893-900. PubMed ID: 8943671 [Abstract] [Full Text] [Related]
2. Neoadjuvant etoposide, ifosfamide, and cisplatin followed by concomitant thoracic radiotherapy and continuous cisplatin infusion in stage IIIb non-small cell lung cancer. Pujol JL, Lafontaine T, Quantin X, Reme-Saumon M, Cupissol D, Khial F, Michel FB. Chest; 1999 Jan; 115(1):144-50. PubMed ID: 9925076 [Abstract] [Full Text] [Related]
3. Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study. Reboul F, Brewer Y, Vincent P, Chauvet B, Faure CF, Taulelle M. Int J Radiat Oncol Biol Phys; 1996 May 01; 35(2):343-50. PubMed ID: 8635942 [Abstract] [Full Text] [Related]
4. Induction chemotherapy plus high-dose radiotherapy versus radiotherapy alone in locally advanced unresectable non-small-cell lung cancer. Crinò L, Latini P, Meacci M, Corgna E, Maranzano E, Darwish S, Minotti V, Santucci A, Tonato M. Ann Oncol; 1993 Dec 01; 4(10):847-51. PubMed ID: 8117604 [Abstract] [Full Text] [Related]
5. Different fraction schedules and combinations with chemotherapy in radiation treatment of non-small cell lung cancer. Brattström D, Bergqvist M, Hesselius P, Wagenius G, Brodin O. Anticancer Res; 2000 Dec 01; 20(3B):2087-90. PubMed ID: 10928157 [Abstract] [Full Text] [Related]
6. Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation Therapy Oncology Group (RTOG) 92-04. Komaki R, Scott C, Ettinger D, Lee JS, Fossella FV, Curran W, Evans RF, Rubin P, Byhardt RW. Int J Radiat Oncol Biol Phys; 1997 Apr 01; 38(1):149-55. PubMed ID: 9212017 [Abstract] [Full Text] [Related]
8. A pilot study of protracted low dose cisplatin and etoposide with concurrent thoracic radiotherapy in unresectable stage III nonsmall cell lung cancer. Blanke C, DeVore R, Shyr Y, Epstein B, Murray M, Hande K, Stewart S, Johnson D. Int J Radiat Oncol Biol Phys; 1997 Jan 01; 37(1):111-6. PubMed ID: 9054884 [Abstract] [Full Text] [Related]
9. Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). Katori H, Tsukuda M, Watai K. Cancer Chemother Pharmacol; 2007 Aug 01; 60(3):399-406. PubMed ID: 17096160 [Abstract] [Full Text] [Related]
10. Prospective trial of combined hyperfractionated radiotherapy and bronchial arterial infusion of chemotherapy for locally advanced nonsmall cell lung cancer. Wang G, Song M, Xu H, Fang Y. Int J Radiat Oncol Biol Phys; 1996 Jan 15; 34(2):309-13. PubMed ID: 8567331 [Abstract] [Full Text] [Related]
12. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group. Komaki R, Scott CB, Sause WT, Johnson DH, Taylor SG, Lee JS, Emami B, Byhardt RW, Curran WJ, Dar AR, Cox JD. Int J Radiat Oncol Biol Phys; 1997 Oct 01; 39(3):537-44. PubMed ID: 9336129 [Abstract] [Full Text] [Related]
13. Long-term results of neoadjuvant ifosfamide, cisplatin, and etoposide combination in locally advanced non-small-cell lung cancer. Pujol JL, Hayot M, Rouanet P, Le Chevalier T, Michel FB. Chest; 1994 Nov 01; 106(5):1451-5. PubMed ID: 7956400 [Abstract] [Full Text] [Related]
14. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma. Hejna M, Kornek GV, Schratter-Sehn AU, Zach M, Schoder M, Raderer M, Rosen H, Schiessel R, Scheithauer W. Cancer; 1996 Oct 15; 78(8):1646-50. PubMed ID: 8859175 [Abstract] [Full Text] [Related]
15. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group. Ariyoshi Y, Fukuoka M, Furuse K, Saijo N, Ikegami H, Nishiwaki Y, Tamura T, Shimoyama M, Suemasu K. Jpn J Clin Oncol; 1994 Oct 15; 24(5):275-81. PubMed ID: 7967106 [Abstract] [Full Text] [Related]
16. How to improve loco-regional control in stages IIIa-b NSCLC? Results of a three-armed randomized trial from the Swedish Lung Cancer Study Group. Nyman J, Friesland S, Hallqvist A, Seke M, Bergström S, Thaning L, Lödén B, Sederholm C, Wagenius G. Lung Cancer; 2009 Jul 15; 65(1):62-7. PubMed ID: 19081652 [Abstract] [Full Text] [Related]
17. Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer. Comella P, Scoppa G, Daponte A, Musetta G, Anania C, Maiorino A, Curcio C, Casaretti R, Comella G. Cancer; 1994 Oct 01; 74(7):1874-81. PubMed ID: 8082093 [Abstract] [Full Text] [Related]
18. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up. Rapidis AD, Trichas M, Stavrinidis E, Roupakia A, Ioannidou G, Kritselis G, Liossi P, Giannakouras G, Douzinas EE, Katsilieris I. Oral Oncol; 2006 Aug 01; 42(7):675-84. PubMed ID: 16731029 [Abstract] [Full Text] [Related]
19. ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d'Etude et Traitement des Cancers Bronchiques), FNCLCC (Féderation Nationale des Centres de Lutte contre le Cancer) and the CEBI trialists. Arriagada R, Le Chevalier T, Quoix E, Ruffie P, de Cremoux H, Douillard JY, Tarayre M, Pignon JP, Laplanche A. Int J Radiat Oncol Biol Phys; 1991 Jun 01; 20(6):1183-90. PubMed ID: 1646194 [Abstract] [Full Text] [Related]